07.29.25 -- Rethinking Large Animal Models In Gene Therapy With Novartis' Ralf Schmid, Ph.D.

Achieve reproducible and robust PSC expansion with proven best practices. This session covers single-cell passaging, perfusion feeding, and in-vessel harvesting.

Explore an improved cartridge for the electroporation of complex cargos into large volumes of T cells. Discover how to achieve reliable, robust, and efficient delivery of complex, clinically relevant cargos.

The shift from "scale-up" to "scale-out" in genetic medicine enhances production speed, revolutionizing pharmaceutical manufacturing and accelerating life-saving therapies for global patient populations.

The client required a freestanding COVID-19 research facility on an accelerated timeline built for continuous use in the cold climate of the northeast United States without a shell building.

What enabled the evolution of TIL therapies? What does the future hold for them? And where should you concentrate your efforts to accelerate progress? Watch for answers to these questions and more.

Expand your knowledge on the latest innovation in the sterile connector space including the new 1.5” flow path connector, disconnection solution, and more.

What are viral-based vectors and why are reproducible quantitation of gene expression important in gene therapy? Explore these questions as well as the interplay among gene therapy vector components.